About NanoCellect Biomedical
NanoCellect Biomedical is a company based in San Diego (United States) founded in 2009 by William Alaynick and Jose Morachis. NanoCellect Biomedical has raised $78.15 million across 23 funding rounds from investors including Agilent, NIH and HHS. The company has 84 employees as of December 31, 2021. NanoCellect Biomedical offers products and services including WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer. NanoCellect Biomedical operates in a competitive market with competitors including ThinkCyte, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others.
- Headquarter San Diego, United States
- Employees 84 as on 31 Dec, 2021
- Founders William Alaynick, Jose Morachis
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanocellect Biomedical Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$78.15 M (USD)
in 23 rounds
-
Latest Funding Round
$28.93 M (USD), Series D
Jun 29, 2023
-
Investors
Agilent
& 12 more
-
Employee Count
84
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoCellect Biomedical
NanoCellect Biomedical offers a comprehensive portfolio of products and services, including WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer.
Benchtop device for gentle microfluidic cell sorting with high viability.
Image-based tool for precise cell sorting in research applications.
Accessory for single-cell deposition in multi-well plates.
Device for temperature control of samples during sorting.
People of NanoCellect Biomedical
Unlock access to complete
Unlock access to complete
Funding Insights of NanoCellect Biomedical
NanoCellect Biomedical has successfully raised a total of $78.15M across 23 strategic funding rounds. The most recent funding activity was a Series D round of $28.93 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NanoCellect Biomedical
NanoCellect Biomedical has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Health tech startups are invested in by Illumina Ventures.
|
Locked | Locked | Locked |
Investor details for NanoCellect Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NanoCellect Biomedical
Investment portfolio details for NanoCellect Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NanoCellect Biomedical
Detailed financials for NanoCellect Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanocellect Biomedical Comparisons
Peer comparison for NanoCellect Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NanoCellect Biomedical
NanoCellect Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ThinkCyte, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| Locked | Locked | Locked |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Cell and molecular-based diagnostics for cancer management are developed.
|
Detailed competitors of NanoCellect Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanocellect Biomedical
Complete news archive for NanoCellect Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoCellect Biomedical
NanoCellect Biomedical was founded in 2009 and raised its 1st funding round 1 year after it was founded.
NanoCellect Biomedical is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Chris Neary is the current CEO of NanoCellect Biomedical.
NanoCellect Biomedical is a funded company, having raised a total of $78.15M across 23 funding rounds to date.
As of Dec 31, 2021, the latest employee count at NanoCellect Biomedical is 84.
NanoCellect Biomedical is a developer of molecular diagnostics, and improve personalized medicine. The company offers WOLF Cell Sorter, which uses a closed fluid-path microfluidic cartridge that enables cell sorting, and avoids biohazard and shear stress issues associated with traditional cell sorters. It claims that this technology sorts cells at the highest purity with almost no loss of viability. This technology has downstream applications of gene expression and sequencing. It also used in sorting rare cells such as circulating tumor cells (CTCs) from blood samples.
NanoCellect Biomedical's top competitors include ThinkCyte, Silicon Biosystems and Singulex.
NanoCellect Biomedical offers WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer.
NanoCellect Biomedical has 13 investors. Key investors include Agilent, NIH, HHS, Warburg Pincus, and National Institute of General Medical Sciences.